<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          Global EditionASIA 中文雙語Fran?ais
          Business
          Home / Business / Latest

          Eli Lilly promotes new drug at CIIE

          By SHI JING in Shanghai | chinadaily.com.cn | Updated: 2019-11-09 09:43
          Share
          Share - WeChat

          Indianapolis-headquartered pharmaceutical company Eli Lilly and Company attended the second China International Import Expo with its latest medicine Taltz to moderate severe plaque psoriasis.

          During the news conference on Thursday, a total of 17 Chinese domestic pharmaceutical companies signed intention agreements with Eli Lilly for the purchase of Taltz. The medicine has been approved by China's National Products Administration in September.

          Eli Lilly and Company was not present at last year's CIIE. Julio Gay-Ger, president and general manager of Lilly China, said that they "were positively surprised by the huge success that CIIE had last year".

          "So we really want to be part of the CIIE in the second year. We have had in the last 12 months five new molecular entities launched in China. This is very close to our record. More importantly, we have up to 40 new launches in the next seven to 10 years. We are bringing innovations to Chinese patients which will make a huge difference to them," he said.

          Gay-Ger said the company has had expectations for Lilly China's sales and business growth.

          "China is the second-largest pharmaceutical market in the world today. It is supposed to be the No 1 pharmaceutical market in the future. It is our top priority market and that is why we are investing so heavily and bringing so much innovation here," he said.

          Lilly set up its Shanghai office in 1918, which was the first overseas office for the US pharmaceutical company. Lilly China's overall growth rate for the first half of 2019 exceeded 30 percent, reaching a record high throughout the company's 101-year history in China.

          Ever since 2013, Lilly has invested about $320 million to build an insulin production facility in Suzhou. The site is set to be an integral part of Lilly's global supply chain, providing insulin products for China, Europe and other markets across the world in 2019.

          "In the future, we can have new launches in China simultaneously or almost simultaneously with other markets in the world. That progress is in part because of the great reform that government is taking, which offers great opportunity to have all that happen," he said.

          Top
          BACK TO THE TOP
          English
          Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
          License for publishing multimedia online 0108263

          Registration Number: 130349
          FOLLOW US
          CLOSE
           
          主站蜘蛛池模板: 东京热大乱系列无码| jizzjizz日本高潮喷水| 免费人成视频网站在线18| 国产精品一码二码三码| 亚洲精品爆乳一区二区H| 国产在线无码视频一区二区三区| 四虎成人免费视频在线播放| 亚洲av无码专区在线亚| 亚洲中文字幕一二三四五六| 国产理论片在线观看| 国产人妻人伦精品婷婷| 久久热在线视频精品视频| 国产成人综合95精品视频| 久久香蕉欧美精品| 国产日产欧洲无码视频无遮挡| 国产高潮大叫在线观看| 人妻少妇久久精品一区二区| 99在线视频免费| 日本无码欧美一区精品久久| 日韩av综合中文字幕| 国产人免费人成免费视频| 国产裸体美女永久免费无遮挡| 午夜精品视频在线看| 久久精品夜色噜噜亚洲av| 亚洲一区二区中文字幕| 狠狠色综合播放一区二区| 四虎永久免费高清视频| 精品国产美女福到在线不卡| 国产精品无圣光一区二区| 亚洲精品揄拍自拍首页一| 亚洲AV成人无码久久精品四虎| 国产精品中文字幕在线看| 亚洲精品日本一区二区| 四虎在线成人免费观看| 日韩有码国产精品一区| 亚洲AV永久无码嘿嘿嘿嘿| 国内精品无码一区二区三区| 日本极品少妇videossexhd| 91精品国产午夜福利| 精品一区二区三区四区五区| 成人无码无遮挡很H在线播放|